HIV pre-exposure prophylaxis for adolescents and young adults

Allen, E., Gordon, A., Krakower, D., Hsu, K.

This review describes the evidence for HIV preexposure prophylaxis (PrEP) with daily combined tenofovir disoproxil fumarate and emtricitabine for adolescents and young adults. Current recommendations are described, as are the unique medical, socioeconomic, and legal considerations regarding the use of PrEP for youth.

August 11, 2017
Year of publication
2017
Resource types
Journal and research articles, Systematic reviews
Tags
pre-exposure prophylaxis (PrEP), PrEP, adolescents, young adults, youth, key populations, HIV prevention, adherence, side effects